Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection

Haematologica

Volumn 93, Issue 1, 2008, Pages 157-158

  Chemaly, Roy F ^a   Torres, Harrys A ^a   Hachem, Ray ^a   Kontoyiannis, Dimitrios P ^a   Safdar, Amar ^a   Raad, Issam I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

DNAemia; Granulocytes transfusion; Human herpesvirus 6; Leukemia; Polymerase chain reaction

Indexed keywords

DNA;

ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULOCYTE TRANSFUSION; HISTORY; HUMAN; HUMAN HERPESVIRUS 6; LEUKEMIA; MOULD; MYCOSIS; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RELAPSE; RISK;

ADULT; ASPERGILLOSIS; ASPERGILLUS; BLOOD TRANSFUSION; DNA, VIRAL; GRANULOCYTES; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA; POLYMERASE CHAIN REACTION; RISK FACTORS; TIME FACTORS;

EID: 38549095224     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11638     Document Type: Article

References (10)

1. Ma XT, Song YH, Lu DM, Mu GF, Li G, Ji LX, et al. Human herpesvirus 6 in hematologic diseases in China. Haematologica 2000;85:458-63.
2. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
3. Wilborn F, Brinkmann V, Schmidt CA, Neipel F, Gelderblom H, Siegert W. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994;83:3052-8.
4. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005;40:932-40.
5. Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, et al. Recombinant interferon γ1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer 2006; 106:2664-71.
6. Palleau S, Boutolleau D, Bonnafous P, Agut H, Gautheret-Dejean A. Polymorphonuclear leukocytes mainly contribute to human herpesvirus-6 load in the peripheral blood of patients. Clin Infect Dis 2006;42:1342-3.
7. Wilborn F, Schmidt CA, Zimmermann R, Brinkmann V, Neipel F, Siegert W. Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies. Br J Haematol 1994; 88:187-92.
8. Imbert-Marcille BM, Tang XW, Lepelletier D, Besse B, Moreau P, Billaudel S, et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 2000;31:881-6.
9. Clark DA, Nacheva EP, Leong HN, Brazma D, Li YT, Tsao EH, et al. Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis 2006;193:912-6.
10. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352: 768-76.